Akèy › Skizofreni › Kalifòni
Etid klinik pou Skizofreni nan Kalifòni
44 etid pou Skizofreni ap chèche patisipan nan sit nan Kalifòni.
Vil nan Kalifòni
- San Diego13 etid
- Garden Grove12 etid
- Inglewood8 etid
- El Cajon8 etid
- Los Angeles8 etid
- Anaheim8 etid
- Orange7 etid
- Torrance6 etid
- Riverside6 etid
- Chino6 etid
- Downey6 etid
- Oceanside6 etid
- Mountain View5 etid
- Westminster5 etid
- Bellflower4 etid
- Norwalk4 etid
- Ontario3 etid
- Concord3 etid
- San Francisco3 etid
- Fullerton3 etid
- San Bernardino3 etid
Tèks ofisyèl etid la (Anglè)
Evaluation of Treatment Satisfaction and KarXT Utilization Registry (RESKU)
- ATP Clinical Research - Costa Mesa, Orange
- Lumos Clinical Research Center, San Jose
Ap rekriteEtid obsèvasyon
Laj 18 ak plis · Tout sèks · Mizajou Sep 30, 2026 · NCT07101094A Study of the Feasibility, Safety and Tolerability of Aticaprant as Adjunctive Treatment in Participants With Schizophrenia
- CNS Network, Garden Grove
Ap rekriteFaz 1
Laj 18 a 55 · Tout sèks · Mizajou Sep 28, 2026 · NCT07615426Relapse Prevention Trial Evaluating KarXT Treatment in Schizophrenia
- Local Institution - 0190, Anaheim
- Local Institution - 0040, Bellflower
- Local Institution - 0188, Chino
- ak 10 plis
Ap rekriteFaz 3
Laj 18 a 65 · Tout sèks · Mizajou Sep 28, 2026 · NCT07686263NBI-1117568-SCZ3032: Long-Term Evaluation of NBI-1117568 in Adults With Schizophrenia
- Neurocrine Clinical Site, Cerritos
- Neurocrine Clinical Site, Chino
- Neurocrine Clinical Site, Culver City
- ak 9 plis
Ap rekriteFaz 3
Laj 18 a 65 · Tout sèks · Mizajou Sep 25, 2026 · NCT07114874Efficacy of NBI-1117568 in Preventing Relapse in Adults With Schizophrenia
- Neurocrine Clinical Site, Garden Grove
- Neurocrine Clinical Site, La Habra
- Neurocrine Clinical Site, Lemon Grove
- ak 2 plis
Ap rekriteFaz 3
Laj 18 a 65 · Tout sèks · Mizajou Sep 25, 2026 · NCT07227818NBI-1117568-SCZ3030: Evaluation of NBI-1117568 in Inpatient Adults With Schizophrenia
- Neurocrine Clinical Site, Culver City
- Neurocrine Clinical Site, Garden Grove
- Neurocrine Clinical Site, Riverside
Ap rekriteFaz 3
Laj 18 a 65 · Tout sèks · Mizajou Sep 25, 2026 · NCT07105098Safety and Tolerability Trial of Lumateperone in Pediatric Patients With Schizophrenia, Bipolar Disorder or Autism Spectrum Disorder
- Advanced Research Center, Inc, Anaheim
- National Institute Of Clinical Research, Garden Grove
- Excell Research Inc, Oceanside
- ak 3 plis
Ap rekriteFaz 3
Laj 5 a 17 · Tout sèks · Mizajou Sep 25, 2026 · NCT06229210A Study of Brenipatide in Adult Participants With Schizophrenia
- Clinical Innovations, Inc. dba CITrials, Bellflower
- Collaborative Neuroscience Research, LLC, Garden Grove
- Catalina Research Institute, LLC, Montclair
- ak 3 plis
Ap rekriteFaz 2
Laj 18 a 55 · Tout sèks · Mizajou Sep 22, 2026 · NCT07410507A Study to Evaluate the Long-term Safety and Tolerability of Xanomeline and Trospium Chloride for the Treatment of Psychiatric Disorders in Children and Adolescents
- Advanced Research Center Inc., Anaheim
- Local Institution - 0159, Anaheim
- Inland Psychiatric Medical Group., Chino
- ak 7 plis
Ap rekriteFaz 3
Laj 5 a 17 · Tout sèks · Mizajou Sep 22, 2026 · NCT07424404A Study to Evaluate the Effectiveness of Valbenazine in Adult Participants With Tardive Dyskinesia (TD) Who Remain Symptomatic While Receiving or After Stopping a Vesicular Monoamine Transporter 2 (VMAT2) Inhibitor
- Neurocrine Clinical Site, Chino
- Neurocrine Clinical Site, Fresno
- Neurocrine Clinical Site, Long Beach
- ak 3 plis
Ap rekriteFaz 4
Laj 18 ak plis · Tout sèks · Mizajou Sep 18, 2026 · NCT07105111A Study of LTX-001 In Adult Participants With Acute Exacerbation of Schizophrenia
- Collaborative Neuroscience Research, LLC, Los Alamitos
Ap rekriteFaz 1
Laj 18 a 55 · Tout sèks · Mizajou Sep 17, 2026 · NCT07734493A Study to Assess Adverse Events, Change in Disease Activity, and How Oral Emraclidine Moves Through the Body in Adult Participants With Schizophrenia
- California Clinical Trials Medical Group - Parexel /ID# 275751, Glendale
- CenExel Collaborative Neuroscience Research /ID# 273005, Los Alamitos
Ap rekriteFaz 2
Laj 18 a 65 · Tout sèks · Mizajou Sep 15, 2026 · NCT0714591852-week Open Label Safety-Tolerability Study
- Advanced Research Center, Anaheim
- Synapse Clinical Trials, Cerritos
- ProScience Research Group, Culver City
- ak 2 plis
Ap rekriteFaz 3
Laj 18 a 65 · Tout sèks · Mizajou Sep 9, 2026 · NCT07369154A Study to Evaluate the Efficacy and Safety of KarXT for the Treatment of Schizophrenia in Adolescents (EMERGENT TEEN)
- Advanced Research Center Inc., Anaheim
- Inland Psychiatric Medical Group., Chino
- Proscience Research Group, Culver City
- ak 1 plis
Ap rekriteFaz 3
Laj 13 a 17 · Tout sèks · Mizajou Sep 4, 2026 · NCT07288567A Study to Evaluate the Safety, Tolerability, and PK of an Injectable Form of KarXT
- Collaborative Neuroscience Research, LLC, Los Alamitos
Ap rekriteFaz 1
Laj 18 a 55 · Tout sèks · Mizajou Sep 2, 2026 · NCT07061288A Long-Term Open-Label Study of ML-007C-MA in Adults With Schizophrenia
- Clinical Site, Bellflower
- Clinical Site, Cerritos
- Clinical Site, Culver City
- ak 12 plis
Ap rekriteFaz 2
Laj 18 a 65 · Tout sèks · Mizajou Sep 1, 2026 · NCT07459647Effectiveness and Adverse-effect Switch Evaluation of Xanomeline and Trospium Chloride (KarXT)
- Pamoja Advanced Nursing Practice, Anaheim
- Local Institution - 0003, Anaheim
- Inland Psychiatric Medical Group (IPMG)-Chino, Chino
- ak 3 plis
Ap rekriteEtid obsèvasyon
Laj 18 ak plis · Tout sèks · Mizajou Aug 19, 2026 · NCT07379827Enhancing Veteran-Clinical Collaboration in VA PRRCs
- VA San Diego Healthcare System, San Diego, CA, San Diego
- VA Greater Los Angeles Healthcare System, West Los Angeles, CA, West Los Angeles
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Aug 19, 2026 · NCT06898879Study to Evaluate Weight Gain as Assessed by Change in BMI Z-score in Pediatric Subjects With Schizophrenia or Bipolar I Disorder
- Alkermes Investigator Site, Stanford
Ap rekriteFaz 3
Laj 10 a 17 · Tout sèks · Mizajou Aug 14, 2026 · NCT05303064Inter-Brain Synchrony in Schizophrenia
- University of California, Los Angeles, Los Angeles
Ap rekriteVolontè an sante akeyi
Laj 18 a 65 · Tout sèks · Mizajou Aug 11, 2026 · NCT07177261Determining Efficacy and Safety of BXCL501 in Agitation Associated With Pediatric Schizophrenia and Bipolar Disorder
- BioXcel Clinical Research Site, Anaheim
Ap rekriteFaz 1
Laj 10 a 17 · Tout sèks · Mizajou Aug 11, 2026 · NCT05025605Improving Cognition Through Telehealth Aerobic Exercise and Cognitive Training After a First Schizophrenia Episode
- UCLA Aftercare Research Program, Los Angeles
Ap rekrite
Laj 18 a 45 · Tout sèks · Mizajou Aug 4, 2026 · NCT05890183Biomarkers to Enhance Early Schizophrenia Treatment
- University of California San Diego, La Jolla
Ap rekriteFaz 4
Laj 18 a 35 · Tout sèks · Mizajou Jul 31, 2026 · NCT06969755Study to Assess the Safety, Tolerability, and Treatment Response of GXV813 in Hospitalized Adults With Schizophrenia
- CNRI Los Angeles LLC, Pico Rivera
Ap rekriteFaz 2
Laj 18 a 65 · Tout sèks · Mizajou Jul 29, 2026 · NCT07467993Study to Evaluate LB-102 for the Treatment of Adult Patients With Acute Schizophrenia
- ProScience Research Group, Culver City
- CenExel, Garden Grove
- Synergy San Diego, Lemon Grove
- ak 1 plis
Ap rekriteFaz 3
Laj 18 a 65 · Tout sèks · Mizajou Jul 27, 2026 · NCT07363577Tolerability of MDMA in Schizophrenia
- UCLA, Los Angeles
Ap rekriteFaz 1/2
Laj 18 a 60 · Tout sèks · Mizajou Jul 17, 2026 · NCT05770375Search for Novel Transcranial Magnetic Stimulation (TMS) Targets for Mental Illness
- Acacia Clinics, Sunnyvale
Ap rekriteFaz 2
Laj 18 a 65 · Tout sèks · Mizajou Jul 16, 2026 · NCT06376734A Study to Evaluate KYN-5356 in Adults With Cognitive Impairment Associated With Schizophrenia
- Synapse Clinical Trials, Cerritos
- Synergy Research Center, Lemon Grove
- Cenexel CNS, Los Alamitos
Ap rekriteFaz 2
Laj 18 a 55 · Tout sèks · Mizajou Jun 23, 2026 · NCT07191483A Study to Evaluate the Effect of KarXT on Urological Safety
- Clinical Innovations, Inc. dba CITrials, Bellflower
- CenExel CNS - Garden Grove, Garden Grove
- ATP Clinical Research, Orange
Ap rekriteFaz 4
Laj 18 a 65 · Tout sèks · Mizajou Jun 3, 2026 · NCT07221877Clozapine for the Prevention of Violence in Schizophrenia: a Randomized Clinical Trial
- University of California, Los Angeles, Los Angeles
Ap rekriteFaz 4
Laj 18 a 65 · Tout sèks · Mizajou May 4, 2026 · NCT05208190Low-dose Buprenorphine as a Modulator of Social Motivation in Schizophrenia
- UCLA Semel Institute, Los Angeles
Ap rekriteFaz 2
Laj 18 a 60 · Tout sèks · Mizajou Apr 28, 2026 · NCT05778591Effects of Brain Stimulation on Cognition, Oscillations and GABA Levels in Schizophrenia
- Imaging Research Center, Sacramento
Ap rekriteVolontè an sante akeyi
Laj 18 a 47 · Tout sèks · Mizajou Mar 30, 2026 · NCT04267003NBI-1117568-SCZ3029: Evaluation of NBI-1117568 in Inpatient Adults With Schizophrenia
- Neurocrine Clinical Site, Anaheim
- Neurocrine Clinical Site, Pico Rivera
- Neurocrine Clinical Site, San Diego
- ak 2 plis
Ap rekriteFaz 3
Laj 18 a 65 · Tout sèks · Mizajou Mar 6, 2026 · NCT06963034Brain Stimulation to the Hippocampus in Schizophrenia
- Stanford University, Stanford
Ap rekriteVolontè an sante akeyi
Laj 18 a 65 · Tout sèks · Mizajou Feb 27, 2026 · NCT07010614Context-Aware Mobile Intervention for Social Recovery in Serious Mental Illness (R33)
- University of California - San Diego, San Diego
Ap rekrite
Laj 18 a 65 · Tout sèks · Mizajou Feb 23, 2026 · NCT06865937Enhancing Rehabilitation for Veterans With Serious Mental Illness
- VA San Diego Healthcare System, San Diego, CA, San Diego
Ap rekrite
Laj 18 a 83 · Tout sèks · Mizajou Jan 30, 2026 · NCT06586164Randomized Clinical Trial of iTEST: A Blended Intervention Targeting Introspective Accuracy
- UC San Diego, San Diego
Ap rekrite
Laj 18 a 65 · Tout sèks · Mizajou Jan 23, 2026 · NCT07098169Single and Multiple Ascending Doses of NTX-253 in Healthy Participants and Participants With Stable Schizophrenia
- Collaborative Neuroscience Research, LLC - CenExel, Los Alamitos
Ap rekriteFaz 1 bonèVolontè an sante akeyi
Laj 18 a 55 · Tout sèks · Mizajou Jan 15, 2026 · NCT07344948Randomized Withdrawal Study in Patients With Schizophrenia
- Vanda Investigational Site, Costa Mesa
- Vanda Investigational Site, Lemon Grove
- Vanda Investigational Site, Oceanside
- ak 3 plis
Ap rekriteFaz 3
Laj 18 a 65 · Tout sèks · Mizajou Jan 12, 2026 · NCT06961968Study of ALTO-101 in Patients With Schizophrenia
- Site 5038, Garden Grove
- Site 5063, Los Angeles
- Site 5106, Orange
- ak 1 plis
Ap rekriteFaz 2
Laj 21 a 55 · Tout sèks · Mizajou Dec 26, 2025 · NCT06502964Sous ClinicalTrials.gov, done yo ranmase Oct 2, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.